• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Alembic Pharmaceuticals Limited — Board Meeting, 04-08-2026: Outcome of Board Meeting

    04-08-2026 | 02:10 pm

    Alembic Pharmaceuticals' board has approved Q1FY27 consolidated financial results. Revenue from operations reached ₹2,149.77 Cr, with a net profit of ₹173.07 Cr. Earnings Per Share stood at ₹8.80 for the quarter.

    No comments yet. Be the first to comment!

    All announcements from Alembic Pharmaceuticals Limited